Research across borders

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find studies Explore world registries Peptide directory

Find a study

Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.

Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 18:18 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase 3RecruitingINTERVENTIONAL

Low-dose Arginine-vasopressin Supplementation on Post-transplant Acute Kidney Injury After Liver Transplantation (AVENIR Trial)

ClinicalTrials.gov · NCT06344442 · Registry updated: 2026-02-05

Condition / research focus: Acute Kidney Injury Post Liver Transplantation
Sponsor: Assistance Publique - Hôpitaux de Paris
Countries with listed sites: France
Registry dates and results: Start: 2025-04-16. Completion: 2027-05-16 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Arginine vasopressin (drug)
Norepinephrine (drug)

Where the study takes place — 1 listed sites

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

URC Lariboisière-Fernand Widal-saint Louis
Paris, France
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 3RecruitingINTERVENTIONAL

Norepinephrine and Vasopressin for Rescue Versus Early Vasopressin for Vasopressor Dependent Sepsis

ClinicalTrials.gov · NCT06464510 · Registry updated: 2026-01-30

Condition / research focus: Septic Shock
Sponsor: Hospital do Coracao
Countries with listed sites: Brazil
Registry dates and results: Start: 2024-11-21. Completion: 2027-09 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Early Vasopressin (drug)
Norepinephrine and Vasopressin for Rescue (drug)

Where the study takes place — 8 listed sites

Hospital Geral de Caxias do Sul
Caxias do Sul, Rio Grande do Sul, Brazil
Site recruitment: Recruiting
Hospital Nereu Ramos
Florianópolis, Santa Catarina, Brazil
Site recruitment: Recruiting
Hospital SEPACO
São Paulo, S, Brazil
Site recruitment: Not yet recruiting
Hospital de Amor - Unidade Barretos (Fundação PIO XII)
Barretos, São Paulo, Brazil
Site recruitment: Not yet recruiting
Hospital do Coracao
São Paulo, São Paulo, Brazil
Site recruitment: Recruiting
BP-A Beneficiência Portuguesa de São Paulo
São Paulo, São Paulo, Brazil
Site recruitment: Not yet recruiting
Hospital Alemão Oswaldo Cruz
São Paulo, São Paulo, Brazil
Site recruitment: Not yet recruiting
Hospital São Paulo - UNIFESP
São Paulo, São Paulo, Brazil
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Probenecid (PB) to Treat Hereditary Nephrogenic Diabetes Insipidus (NDI), ADPKD Treated With Tolvaptan, and Severely Polyuric Patients With Previous Lithium Administration

ClinicalTrials.gov · NCT05190744 · Registry updated: 2026-01-27

Condition / research focus: Autosomal Dominant Polycystic Kidney Disease; Nephrogenic Diabetes Insipidus; Acquired Nephrogenic Diabetes Insipidus; Congenital Nephrogenic Diabetes Insipidus
Sponsor: Mayo Clinic
Countries with listed sites: United States
Registry dates and results: Start: 2022-09-01. Completion: 2025-12-08 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

PB (drug)

Where the study takes place — 1 listed sites

Mayo Clinic
Jacksonville, Florida, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Vasopressin in the Elderly: Physiological Changes in Neuroendocrine Function and Urinary Secretion in Healthy Aging

ClinicalTrials.gov · NCT06930300 · Registry updated: 2026-01-13

Condition / research focus: Healthy Ageing
Sponsor: University Hospital, Basel, Switzerland
Countries with listed sites: Switzerland
Registry dates and results: Start: 2025-04-30. Completion: 2025-10-10 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Hypertonic 3% saline (other)
Water (other)

Where the study takes place — 1 listed sites

University Hospital Basel
Basel, Canton of Basel-City, Switzerland
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4RecruitingINTERVENTIONAL

Vasoactive Drugs in Intensive Care Unit

ClinicalTrials.gov · NCT02118467 · Registry updated: 2026-01-13

Condition / research focus: Shock
Sponsor: University of Chicago
Countries with listed sites: United States
Registry dates and results: Start: 2014-05-15. Completion: 2026-12-01 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Norepinephrine (drug) — also listed as: Levophed
Epinephrine (drug)
Phenylephrine (drug) — also listed as: Neo-Synephrine
Vasopressin (drug) — also listed as: Pitressin

Where the study takes place — 1 listed sites

University of Chicago Medical Center
Chicago, Illinois, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Ginkgo Biloba vs Desmopressin in Treatment of Children With Monosymptomatic Nocturnal Enuresis

ClinicalTrials.gov · NCT06771128 · Registry updated: 2026-01-13

Condition / research focus: Nocturnal Enuresis in Children; Desmopressin; Monosymptomatic Nocturnal Enuresis
Sponsor: Menoufia University
Countries with listed sites: Egypt
Registry dates and results: Start: 2024-11-01. Completion: 2026-01-01 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Ginkgo Biloba oral tablet (drug)
Desmopressin Acetate 0.2 mg Tablets (drug)
Ginkgo Biloba like Placebo (drug)
Desmopressin like Placebo (drug)

Where the study takes place — 1 listed sites

Menoufia Faculty of Medicine
Shebin El-Kom, Menoufia, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableRecruitingOBSERVATIONAL

Detecting Mild Autonomous Cortisol Secretion in Patients With Adrenal Incidentaloma

ClinicalTrials.gov · NCT06344143 · Registry updated: 2026-01-08

Condition / research focus: Mild Autonomous Cortisol Secretion (MACS)
Sponsor: The Cleveland Clinic
Countries with listed sites: United States
Registry dates and results: Start: 2024-11-20. Completion: 2030-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Various labs and imaging tests (diagnostic_test)

Where the study takes place — 1 listed sites

The Cleveland Clinic Foundation
Cleveland, Ohio, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 3RecruitingINTERVENTIONAL

Weaning Approaches for Vasopressin in Sepsis

ClinicalTrials.gov · NCT07067866 · Registry updated: 2026-01-02

Condition / research focus: Septic Shock
Sponsor: Hospital Nossa Senhora da Conceicao
Countries with listed sites: Brazil
Registry dates and results: Start: 2025-10-01. Completion: 2028-10-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Titrated weaning of vasopressin. (other)
Abrupt weaning of vasopressin. (other)

Where the study takes place — 1 listed sites

Hospital Nossa Senhora da Conceição
Porto Alegre, Rio Grande do Sul, Brazil
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 3Active, not recruitingINTERVENTIONAL

Evaluation of the Superiority of VAsopressin Versus NOradrenaline in the Management of Patients at Risk of Kidney Failure Undergoing Cardiac Surgery With Extracorporeal Circulation

ClinicalTrials.gov · NCT05568160 · Registry updated: 2025-12-22

Condition / research focus: Scheduled Cardiac Surgery With Extracorporeal Circulation; Vasoplegic Syndrome
Sponsor: Centre Hospitalier Universitaire Dijon
Countries with listed sites: France
Registry dates and results: Start: 2023-01-02. Completion: 2026-03 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Vasopressin (drug)
Norepinephrine (drug)
Collection of clinical data (other)
Quality of Life Questionnaire EQ-5D (other)

Where the study takes place — 1 listed sites

Chu Dijon Bourgogne
Dijon, France
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableRecruitingINTERVENTIONAL

Echocardiography-guided Cirrhosis and Liver Failure-Intensive Care Protocol Sepsis

ClinicalTrials.gov · NCT07286643 · Registry updated: 2025-12-16

Condition / research focus: Cirrhosis, Liver; Cirrhotic Cardiomyopathy; Septic Shock
Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh
Countries with listed sites: India
Registry dates and results: Start: 2026-01-01. Completion: 2028-12-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

POCUS (diagnostic_test)
Fixed Resuscitation Strategy based on Target MAP (diagnostic_test)

Where the study takes place — 1 listed sites

PGIMER Chandigarh
Chandigarh, India
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Mannitol-induced Release of Copeptin in Healthy Adults and Patients With Polyuria-Polydipsia Syndrome (MARS Study)

ClinicalTrials.gov · NCT06542198 · Registry updated: 2025-12-15

Condition / research focus: Polyuria-polydipsia Syndrome; Arginine Vasopressin Deficiency; Primary Polydipsia
Sponsor: University Hospital, Basel, Switzerland
Countries with listed sites: Switzerland
Registry dates and results: Start: 2024-09-10. Completion: 2025-07-22 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Mannitol Infusion (blinded) (diagnostic_test)
Placebo Infusion (blinded) (diagnostic_test)
Mannitol Infusion (open label) (diagnostic_test)

Where the study takes place — 1 listed sites

University Hospital Basel
Basel, Switzerland
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableRecruitingOBSERVATIONAL

Use of Vassopresin in Septic Shock Prospective Multicenter Observational Study With Medication

ClinicalTrials.gov · NCT07255378 · Registry updated: 2025-12-15

Condition / research focus: Septic Shock
Sponsor: Jamil Cedeño Mora
Countries with listed sites: Spain
Registry dates and results: Start: 2025-10-01. Completion: 2028-01-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Usage of vasopressin (VAP) as a second-line vasopressor in septic shock patients. (drug)

Where the study takes place — 12 listed sites

Consorci Sanitari de Terrassa
Terrassa, BARCELONA, Spain
Site recruitment: Recruiting
Hospital Universitario de Getafe
Getafe, Madrid, Spain
Site recruitment: Recruiting
Hospital Universitario La Princesa
Madrid, Madrid, Spain
Site recruitment: Recruiting
Hospital General Universitario Gregorio Marañón
Madrid, Madrid, Spain
Site recruitment: Recruiting
Hospital Universitario Ramón y Cajal
Madrid, Madrid, Spain
Site recruitment: Recruiting
Hospital Universitario Clínico San Carlos
Madrid, Madrid, Spain
Site recruitment: Recruiting
Hospital Universitario Doce de Octubre
Madrid, Madrid, Spain
Site recruitment: Recruiting
Hospital Universitario La Paz
Madrid, Madrid, Spain
Site recruitment: Recruiting
Hospital Universitario Puerta de Hierro
Majadahonda, Madrid, Spain
Site recruitment: Recruiting
Hospital Universitario Rey Juan Carlos
Móstoles, Madrid, Spain
Site recruitment: Recruiting
Hospital Universitario y Politécnico de La Fe
Valencia, Valencia, Spain
Site recruitment: Recruiting
Hospital Universitario Miguel Servet
Zaragoza, ZARAGOZA, Spain
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Terlipressin in Combined Hepatorenal Syndrome in Patients With Signs of Chronic Renal Disease

ClinicalTrials.gov · NCT06161766 · Registry updated: 2025-12-05

Condition / research focus: Liver Cirrhosis; Hepato-Renal Syndrome; Chronic Kidney Diseases
Sponsor: University Hospital Freiburg
Countries with listed sites: Germany
Registry dates and results: Start: 2024-03-03. Completion: 2024-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

terlipressin or noradrenalin plus albumin (drug)

Where the study takes place — 4 listed sites

University Medical Center Freiburg
Freiburg im Breisgau, Germany
Site recruitment: Not reported
University Medical center Jena
Jena, Germany
Site recruitment: Not reported
University Medical Center Mainz
Mainz, Germany
Site recruitment: Not reported
University Hospital Münster
Münster, Germany
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Hydration to Optimize Metabolism

ClinicalTrials.gov · NCT03422848 · Registry updated: 2025-12-02

Condition / research focus: Glucose, High Blood
Sponsor: Region Skane
Countries with listed sites: Sweden
Registry dates and results: Start: 2018-04-24. Completion: 2025-11-03 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Water (dietary_supplement)
general life style advice (behavioral)

Where the study takes place — 1 listed sites

KFE, Skåne University Hospital in Malmö
Malmö, Sweden
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableRecruitingINTERVENTIONAL

The Effect of Prehospital Combination of Epinephrine, Vasopressin, and Steroid in OHCA

ClinicalTrials.gov · NCT06203847 · Registry updated: 2025-11-19

Condition / research focus: Cardiac Arrest; Out-Of-Hospital Cardiac Arrest; Emergency Medical Services
Sponsor: National Taiwan University Hospital
Countries with listed sites: Taiwan
Registry dates and results: Start: 2024-07-16. Completion: 2026-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Combination group (drug)
Standard group (drug)

Where the study takes place — 1 listed sites

National Taiwan University Hospital
Taipei, Taiwan
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase not reported / not applicableRecruitingOBSERVATIONAL

Sleep Disorders in Hypothalamic and Pituitary Damage

ClinicalTrials.gov · NCT07143266 · Registry updated: 2025-11-18

Condition / research focus: Hypopituitarism; Sleep Wake Disorders; Hypothalamic Diseases; Oxytocin Deficiency
Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Countries with listed sites: Spain
Registry dates and results: Start: 2025-09-01. Completion: 2027-12 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

This is an observational study. No drugs will be administered (other)

Where the study takes place — 1 listed sites

Hospital de la Santa Creu i Sant Pau
Barcelona, Spain
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Potential Benefits of the Somatic Psychoeducational Intervention

ClinicalTrials.gov · NCT05766852 · Registry updated: 2025-11-10

Condition / research focus: Work Related Stress
Sponsor: University of Florida
Countries with listed sites: United States
Registry dates and results: Start: 2023-10-23. Completion: 2024-04-11 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Somatic Psychoeducational Intervention (behavioral)

Where the study takes place — 1 listed sites

UF Health Jacksonville
Jacksonville, Florida, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2RecruitingINTERVENTIONAL

Effects of Intranasal Oxytocin on Sexual Well-Being in Patients With Arginine Vasopressin Deficiency and Healthy Controls

ClinicalTrials.gov · NCT06808516 · Registry updated: 2025-10-03

Condition / research focus: Arginine Vasopressin Deficiency; Central Diabetes Insipidus; Oxytocin Deficiency
Sponsor: University Hospital, Basel, Switzerland
Countries with listed sites: Switzerland
Registry dates and results: Start: 2025-07-01. Completion: 2026-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin nasal spray (drug) — also listed as: Syntocinon
Placebo (drug)

Where the study takes place — 1 listed sites

University Hospital Basel
Basel, Switzerland
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

The Effects of Oxytocin and Vasopressin on Delta-beta Cross-frequency Coupling

ClinicalTrials.gov · NCT06605300 · Registry updated: 2025-10-03

Condition / research focus: Healthy
Sponsor: University of Electronic Science and Technology of China
Countries with listed sites: China
Registry dates and results: Start: 2024-10-02. Completion: 2025-08-12 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Intranasal Oxytocin (IN-OXT) (drug)
Intranasal Vasopressin (AVP) (drug)
Intranasal Placebo (drug)

Where the study takes place — 2 listed sites

University of Electronic Science and Technology of China
Chengdu, Chengdu, China
Site recruitment: Not reported
University of Electronic Science and Technology of China (UESTC)
Chengdu, Sichuan, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3RecruitingINTERVENTIONAL

Omegapres Versus Solifenacin and Mirabegron Combination Therapy in Treatment of Primary MNE

ClinicalTrials.gov · NCT07199894 · Registry updated: 2025-09-30

Condition / research focus: Nocturnal Enuresis in Children
Sponsor: Mansoura University
Countries with listed sites: Egypt
Registry dates and results: Start: 2024-12-01. Completion: 2026-02-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Mirabegron (beta3-adrenoceptor agonist), Anticholinergics (drug)
Desmopressin (DDAVP) (drug)

Where the study takes place — 1 listed sites

Urology and Nephrology center - Mansoura University
Al Mansurah, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Explore the world’s study registries

These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.

Worldwide

Africa

Pan African Clinical Trial Registry ↗

Americas

Asia

Middle East

Europe

Oceania

Australia / New Zealand — ANZCTR ↗

Registry directory checked October 5, 2026 against the WHO registry network. This is a starting point, not complete coverage of every country or continent. Record availability, language and update schedules vary by registry.

Worldwide Study Finder

Loading registry information…

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find a study

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 18:18 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase 3RecruitingINTERVENTIONAL

Low-dose Arginine-vasopressin Supplementation on Post-transplant Acute Kidney Injury After Liver Transplantation (AVENIR Trial)

ClinicalTrials.gov · NCT06344442 · Registry updated: 2026-02-05

Condition / research focus: Acute Kidney Injury Post Liver Transplantation
Sponsor: Assistance Publique - Hôpitaux de Paris
Countries with listed sites: France
Registry dates and results: Start: 2025-04-16. Completion: 2027-05-16 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Arginine vasopressin (drug)
Norepinephrine (drug)

Where the study takes place — 1 listed sites

URC Lariboisière-Fernand Widal-saint Louis
Paris, France
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 3RecruitingINTERVENTIONAL

Norepinephrine and Vasopressin for Rescue Versus Early Vasopressin for Vasopressor Dependent Sepsis

ClinicalTrials.gov · NCT06464510 · Registry updated: 2026-01-30

Condition / research focus: Septic Shock
Sponsor: Hospital do Coracao
Countries with listed sites: Brazil
Registry dates and results: Start: 2024-11-21. Completion: 2027-09 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Early Vasopressin (drug)
Norepinephrine and Vasopressin for Rescue (drug)

Where the study takes place — 8 listed sites

Hospital Geral de Caxias do Sul
Caxias do Sul, Rio Grande do Sul, Brazil
Site recruitment: Recruiting
Hospital Nereu Ramos
Florianópolis, Santa Catarina, Brazil
Site recruitment: Recruiting
Hospital SEPACO
São Paulo, S, Brazil
Site recruitment: Not yet recruiting
Hospital de Amor - Unidade Barretos (Fundação PIO XII)
Barretos, São Paulo, Brazil
Site recruitment: Not yet recruiting
Hospital do Coracao
São Paulo, São Paulo, Brazil
Site recruitment: Recruiting
BP-A Beneficiência Portuguesa de São Paulo
São Paulo, São Paulo, Brazil
Site recruitment: Not yet recruiting
Hospital Alemão Oswaldo Cruz
São Paulo, São Paulo, Brazil
Site recruitment: Not yet recruiting
Hospital São Paulo - UNIFESP
São Paulo, São Paulo, Brazil
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Probenecid (PB) to Treat Hereditary Nephrogenic Diabetes Insipidus (NDI), ADPKD Treated With Tolvaptan, and Severely Polyuric Patients With Previous Lithium Administration

ClinicalTrials.gov · NCT05190744 · Registry updated: 2026-01-27

Condition / research focus: Autosomal Dominant Polycystic Kidney Disease; Nephrogenic Diabetes Insipidus; Acquired Nephrogenic Diabetes Insipidus; Congenital Nephrogenic Diabetes Insipidus
Sponsor: Mayo Clinic
Countries with listed sites: United States
Registry dates and results: Start: 2022-09-01. Completion: 2025-12-08 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

PB (drug)

Where the study takes place — 1 listed sites

Mayo Clinic
Jacksonville, Florida, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Vasopressin in the Elderly: Physiological Changes in Neuroendocrine Function and Urinary Secretion in Healthy Aging

ClinicalTrials.gov · NCT06930300 · Registry updated: 2026-01-13

Condition / research focus: Healthy Ageing
Sponsor: University Hospital, Basel, Switzerland
Countries with listed sites: Switzerland
Registry dates and results: Start: 2025-04-30. Completion: 2025-10-10 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Hypertonic 3% saline (other)
Water (other)

Where the study takes place — 1 listed sites

University Hospital Basel
Basel, Canton of Basel-City, Switzerland
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4RecruitingINTERVENTIONAL

Vasoactive Drugs in Intensive Care Unit

ClinicalTrials.gov · NCT02118467 · Registry updated: 2026-01-13

Condition / research focus: Shock
Sponsor: University of Chicago
Countries with listed sites: United States
Registry dates and results: Start: 2014-05-15. Completion: 2026-12-01 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Norepinephrine (drug) — also listed as: Levophed
Epinephrine (drug)
Phenylephrine (drug) — also listed as: Neo-Synephrine
Vasopressin (drug) — also listed as: Pitressin

Where the study takes place — 1 listed sites

University of Chicago Medical Center
Chicago, Illinois, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Ginkgo Biloba vs Desmopressin in Treatment of Children With Monosymptomatic Nocturnal Enuresis

ClinicalTrials.gov · NCT06771128 · Registry updated: 2026-01-13

Condition / research focus: Nocturnal Enuresis in Children; Desmopressin; Monosymptomatic Nocturnal Enuresis
Sponsor: Menoufia University
Countries with listed sites: Egypt
Registry dates and results: Start: 2024-11-01. Completion: 2026-01-01 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Ginkgo Biloba oral tablet (drug)
Desmopressin Acetate 0.2 mg Tablets (drug)
Ginkgo Biloba like Placebo (drug)
Desmopressin like Placebo (drug)

Where the study takes place — 1 listed sites

Menoufia Faculty of Medicine
Shebin El-Kom, Menoufia, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableRecruitingOBSERVATIONAL

Detecting Mild Autonomous Cortisol Secretion in Patients With Adrenal Incidentaloma

ClinicalTrials.gov · NCT06344143 · Registry updated: 2026-01-08

Condition / research focus: Mild Autonomous Cortisol Secretion (MACS)
Sponsor: The Cleveland Clinic
Countries with listed sites: United States
Registry dates and results: Start: 2024-11-20. Completion: 2030-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Various labs and imaging tests (diagnostic_test)

Where the study takes place — 1 listed sites

The Cleveland Clinic Foundation
Cleveland, Ohio, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 3RecruitingINTERVENTIONAL

Weaning Approaches for Vasopressin in Sepsis

ClinicalTrials.gov · NCT07067866 · Registry updated: 2026-01-02

Condition / research focus: Septic Shock
Sponsor: Hospital Nossa Senhora da Conceicao
Countries with listed sites: Brazil
Registry dates and results: Start: 2025-10-01. Completion: 2028-10-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Titrated weaning of vasopressin. (other)
Abrupt weaning of vasopressin. (other)

Where the study takes place — 1 listed sites

Hospital Nossa Senhora da Conceição
Porto Alegre, Rio Grande do Sul, Brazil
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 3Active, not recruitingINTERVENTIONAL

Evaluation of the Superiority of VAsopressin Versus NOradrenaline in the Management of Patients at Risk of Kidney Failure Undergoing Cardiac Surgery With Extracorporeal Circulation

ClinicalTrials.gov · NCT05568160 · Registry updated: 2025-12-22

Condition / research focus: Scheduled Cardiac Surgery With Extracorporeal Circulation; Vasoplegic Syndrome
Sponsor: Centre Hospitalier Universitaire Dijon
Countries with listed sites: France
Registry dates and results: Start: 2023-01-02. Completion: 2026-03 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Vasopressin (drug)
Norepinephrine (drug)
Collection of clinical data (other)
Quality of Life Questionnaire EQ-5D (other)

Where the study takes place — 1 listed sites

Chu Dijon Bourgogne
Dijon, France
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableRecruitingINTERVENTIONAL

Echocardiography-guided Cirrhosis and Liver Failure-Intensive Care Protocol Sepsis

ClinicalTrials.gov · NCT07286643 · Registry updated: 2025-12-16

Condition / research focus: Cirrhosis, Liver; Cirrhotic Cardiomyopathy; Septic Shock
Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh
Countries with listed sites: India
Registry dates and results: Start: 2026-01-01. Completion: 2028-12-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

POCUS (diagnostic_test)
Fixed Resuscitation Strategy based on Target MAP (diagnostic_test)

Where the study takes place — 1 listed sites

PGIMER Chandigarh
Chandigarh, India
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Mannitol-induced Release of Copeptin in Healthy Adults and Patients With Polyuria-Polydipsia Syndrome (MARS Study)

ClinicalTrials.gov · NCT06542198 · Registry updated: 2025-12-15

Condition / research focus: Polyuria-polydipsia Syndrome; Arginine Vasopressin Deficiency; Primary Polydipsia
Sponsor: University Hospital, Basel, Switzerland
Countries with listed sites: Switzerland
Registry dates and results: Start: 2024-09-10. Completion: 2025-07-22 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Mannitol Infusion (blinded) (diagnostic_test)
Placebo Infusion (blinded) (diagnostic_test)
Mannitol Infusion (open label) (diagnostic_test)

Where the study takes place — 1 listed sites

University Hospital Basel
Basel, Switzerland
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableRecruitingOBSERVATIONAL

Use of Vassopresin in Septic Shock Prospective Multicenter Observational Study With Medication

ClinicalTrials.gov · NCT07255378 · Registry updated: 2025-12-15

Condition / research focus: Septic Shock
Sponsor: Jamil Cedeño Mora
Countries with listed sites: Spain
Registry dates and results: Start: 2025-10-01. Completion: 2028-01-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Usage of vasopressin (VAP) as a second-line vasopressor in septic shock patients. (drug)

Where the study takes place — 12 listed sites

Consorci Sanitari de Terrassa
Terrassa, BARCELONA, Spain
Site recruitment: Recruiting
Hospital Universitario de Getafe
Getafe, Madrid, Spain
Site recruitment: Recruiting
Hospital Universitario La Princesa
Madrid, Madrid, Spain
Site recruitment: Recruiting
Hospital General Universitario Gregorio Marañón
Madrid, Madrid, Spain
Site recruitment: Recruiting
Hospital Universitario Ramón y Cajal
Madrid, Madrid, Spain
Site recruitment: Recruiting
Hospital Universitario Clínico San Carlos
Madrid, Madrid, Spain
Site recruitment: Recruiting
Hospital Universitario Doce de Octubre
Madrid, Madrid, Spain
Site recruitment: Recruiting
Hospital Universitario La Paz
Madrid, Madrid, Spain
Site recruitment: Recruiting
Hospital Universitario Puerta de Hierro
Majadahonda, Madrid, Spain
Site recruitment: Recruiting
Hospital Universitario Rey Juan Carlos
Móstoles, Madrid, Spain
Site recruitment: Recruiting
Hospital Universitario y Politécnico de La Fe
Valencia, Valencia, Spain
Site recruitment: Recruiting
Hospital Universitario Miguel Servet
Zaragoza, ZARAGOZA, Spain
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Terlipressin in Combined Hepatorenal Syndrome in Patients With Signs of Chronic Renal Disease

ClinicalTrials.gov · NCT06161766 · Registry updated: 2025-12-05

Condition / research focus: Liver Cirrhosis; Hepato-Renal Syndrome; Chronic Kidney Diseases
Sponsor: University Hospital Freiburg
Countries with listed sites: Germany
Registry dates and results: Start: 2024-03-03. Completion: 2024-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

terlipressin or noradrenalin plus albumin (drug)

Where the study takes place — 4 listed sites

University Medical Center Freiburg
Freiburg im Breisgau, Germany
Site recruitment: Not reported
University Medical center Jena
Jena, Germany
Site recruitment: Not reported
University Medical Center Mainz
Mainz, Germany
Site recruitment: Not reported
University Hospital Münster
Münster, Germany
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Hydration to Optimize Metabolism

ClinicalTrials.gov · NCT03422848 · Registry updated: 2025-12-02

Condition / research focus: Glucose, High Blood
Sponsor: Region Skane
Countries with listed sites: Sweden
Registry dates and results: Start: 2018-04-24. Completion: 2025-11-03 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Water (dietary_supplement)
general life style advice (behavioral)

Where the study takes place — 1 listed sites

KFE, Skåne University Hospital in Malmö
Malmö, Sweden
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableRecruitingINTERVENTIONAL

The Effect of Prehospital Combination of Epinephrine, Vasopressin, and Steroid in OHCA

ClinicalTrials.gov · NCT06203847 · Registry updated: 2025-11-19

Condition / research focus: Cardiac Arrest; Out-Of-Hospital Cardiac Arrest; Emergency Medical Services
Sponsor: National Taiwan University Hospital
Countries with listed sites: Taiwan
Registry dates and results: Start: 2024-07-16. Completion: 2026-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Combination group (drug)
Standard group (drug)

Where the study takes place — 1 listed sites

National Taiwan University Hospital
Taipei, Taiwan
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase not reported / not applicableRecruitingOBSERVATIONAL

Sleep Disorders in Hypothalamic and Pituitary Damage

ClinicalTrials.gov · NCT07143266 · Registry updated: 2025-11-18

Condition / research focus: Hypopituitarism; Sleep Wake Disorders; Hypothalamic Diseases; Oxytocin Deficiency
Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Countries with listed sites: Spain
Registry dates and results: Start: 2025-09-01. Completion: 2027-12 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

This is an observational study. No drugs will be administered (other)

Where the study takes place — 1 listed sites

Hospital de la Santa Creu i Sant Pau
Barcelona, Spain
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Potential Benefits of the Somatic Psychoeducational Intervention

ClinicalTrials.gov · NCT05766852 · Registry updated: 2025-11-10

Condition / research focus: Work Related Stress
Sponsor: University of Florida
Countries with listed sites: United States
Registry dates and results: Start: 2023-10-23. Completion: 2024-04-11 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Somatic Psychoeducational Intervention (behavioral)

Where the study takes place — 1 listed sites

UF Health Jacksonville
Jacksonville, Florida, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2RecruitingINTERVENTIONAL

Effects of Intranasal Oxytocin on Sexual Well-Being in Patients With Arginine Vasopressin Deficiency and Healthy Controls

ClinicalTrials.gov · NCT06808516 · Registry updated: 2025-10-03

Condition / research focus: Arginine Vasopressin Deficiency; Central Diabetes Insipidus; Oxytocin Deficiency
Sponsor: University Hospital, Basel, Switzerland
Countries with listed sites: Switzerland
Registry dates and results: Start: 2025-07-01. Completion: 2026-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin nasal spray (drug) — also listed as: Syntocinon
Placebo (drug)

Where the study takes place — 1 listed sites

University Hospital Basel
Basel, Switzerland
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

The Effects of Oxytocin and Vasopressin on Delta-beta Cross-frequency Coupling

ClinicalTrials.gov · NCT06605300 · Registry updated: 2025-10-03

Condition / research focus: Healthy
Sponsor: University of Electronic Science and Technology of China
Countries with listed sites: China
Registry dates and results: Start: 2024-10-02. Completion: 2025-08-12 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Intranasal Oxytocin (IN-OXT) (drug)
Intranasal Vasopressin (AVP) (drug)
Intranasal Placebo (drug)

Where the study takes place — 2 listed sites

University of Electronic Science and Technology of China
Chengdu, Chengdu, China
Site recruitment: Not reported
University of Electronic Science and Technology of China (UESTC)
Chengdu, Sichuan, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3RecruitingINTERVENTIONAL

Omegapres Versus Solifenacin and Mirabegron Combination Therapy in Treatment of Primary MNE

ClinicalTrials.gov · NCT07199894 · Registry updated: 2025-09-30

Condition / research focus: Nocturnal Enuresis in Children
Sponsor: Mansoura University
Countries with listed sites: Egypt
Registry dates and results: Start: 2024-12-01. Completion: 2026-02-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Mirabegron (beta3-adrenoceptor agonist), Anticholinergics (drug)
Desmopressin (DDAVP) (drug)

Where the study takes place — 1 listed sites

Urology and Nephrology center - Mansoura University
Al Mansurah, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →